Karlsruhe – Since 2004 more than 100,000 patients in 30 countries (up to August 2014) have undergone surgery with the TESSYS® method and its later developments. The latest studies reveal a shorter recovery time, a quicker return to work and normal quality of life, and an associated reduction in the impact on welfare systems.
joimax® looks back on 10 years of successful application of the TESSYS® procedure for minimally invasive endoscopic removal of herniated discs – a particularly gentle surgical technique using the naturally occurring transforaminal opening to the spinal canal. TESSYS® was the first product that joimax® launched onto the market and it helped the company make its breakthrough. Since then, joimax® has greatly diversified its product portfolio for 360° surgery in virtually all areas of the spinal column, including endoscopic and percutaneous stabilization.
Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore. In this exclusive deal, Transmedic will represent joimax® in Singapore, Hong Kong, Philippines and Indonesia.
The long-term partnership will provide a broader surgical choice for patients considering endoscopic minimally invasive spinal surgery in these markets. With recent advances in the field of endoscopic discectomy (ED), the procedure has potential to supersedemicrodiscectomy (MD) as the gold standard of care in management of lumbar disc disease, as the latest literature suggests.
“joimax® is very much looking forward to working with Transmedic Group,” says joimax® Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.”
Teo Kee Meng, managing director of Transmedic Group commented, “We’re very pleased to partner with joimax®. With their technological advancements and use of new spinal access corridors, a major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times.”
About Transmedic Group
Transmedic Group was founded in 1980 with the aim of becoming the top specialist in the advanced medical technology area in Southeast Asia. Headquartered in Singapore, the privately held company has since grown its presence in seven countries with more than 500 employees, and is well-renowned as the leading provider of latest technologies in healthcare.
Karlsruhe, 23 October 2012. joimax® as the recognized pioneer in endoscopic spine surgery has launched the transforaminal access to the spinal canal under the brand name TESSYS® in 2004. Since then the company has consistently extended its product range and covers the complete array of therapies for spinal disorders with its systems today.
TESSYS® and iLESSYS® are applied especially for the treatment of disc herniations and stenosis utilizing the transforaminal or interlaminar access to the spinal canal, aiming for a long lasting decompression. In the area of pain therapy the company offers the products of the Multiuse series for endoscopic rhizotomy and PeNuts® for percutaneous nucleus therapy. The product range is completed by systems and products in the field of VBA management.
Consequently the next step in the evolution of the joimax® product portfolio is the stabilization and restoration of the spinal column. With the joimax® EndoLIF® programme – the term stands for Endoscopic Lumbar Interbody Fusion – various cage technologies are brought into the intervertebral foramen step by step under endoscopic view. The cage is then being filled with autologous bone or a substitute material under endoscopic control also, the intervertebral disc space and hence the whole spine segment is raised and stabilized. This will be the world’s first interbody fusion device which can be inserted under direct vision.
EndoSphere Spine’s founding members Professors Vijay Goel, PhD and Anand Agarwal, MD at the University of Toledo are among the world leading researchers in the development of biomedical device for the spine. With the assistance of a team at the University of Toledo, they have developed the cage technology, in particular a novel ring cage that is being licensed to joimax® on an exclusive worldwide basis. Prof. Goel is enthusiastic with the idea to position the cage technology using the joimax® minimally invasive access technique: “The combination of our know how with the joimax® expertise leads us to a unique concept that will dramatically push endoscopic spinal surgery forward.” His colleague Prof. Agarwal considers it even a “quantum leap forward”. “In the team at the University of Toledo and the co-founders of EndoSphere Spine, LLC (Profs Goel and Agarwal) we have found a brilliant partner to provide the spine surgeons with state-of-the-art implants for most atraumatic interventions”, adds Wolfgang Ries, CEO and Founder of joimax®.
Both parties share the vision and mission of creating pioneering technologies in order to quickly bring back patients to their usual quality of life in the long run.
About The University of Toledo
Established in 1872, The University of Toledo is home to nearly 22,500 students across 13 colleges and six Ohio campuses. The University offers more than 230 doctoral, professional, graduate and undergraduate programs. UT has earned national and international acclaim for its expertise in medical bioengineering, solar and advanced renewable energy, environmental sciences, astronomical research, translational research and biomarkers.
Irvine, California – July 13, 2015 (BUSINESS WIRE) – The German company joimax®, developer of technologies and training methods for minimally invasive endoscopic spinal surgery, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endoscopic Lumbar Interbody Fusion, or EndoLIF® On-Cage.
The EndoLIF On-Cage® consists of titanium alloy, produced with Electron Beam Melt (EBM) technology. The cage displays a porous surface with diamond cell structure, providing an optimal base for cell proliferation and bone growth. Two large openings, which may be filled with autogenous bone, support the creation of a straight column for fusion.
The EndoLIF® implant allows surgeons to utilize an inter-muscular approach, similar to a mini transforaminal lumbar interbody fusion (TLIF), into the intervertebral disc, enabling endoscopic-assisted fusion. Dr. Ralf Wagner, LIGAMENTA Spine Center, Frankfurt and Dr. Bernd Illerhaus, ONZ, Datteln/Recklinghausen, two German spine specialists, have already performed more than 200 out of 600 EndoLIF procedures in Europe. “The access is dura and nerve-gentle, preserves the dorsal bony structures and we can avoid scar tissue because of the stepwise tissue dilation,” said Dr. Illerhaus.
The EndoLIF® On-Cage is designed to be used with supplemental posterior fixation, such as the joimax Percusys® percutaneous pedicle screw-rod system. Cage implantation can be performed with a posterior or postero-lateral approach, either using an open or endoscopic-assisted method.
“With the EndoLIF® program, joimax offers a complete endoscopic-assisted solution for spinal stabilization and fusion. In the future, we will be able to treat patients with even more gentle techniques,” comments Wolfgang Ries, CEO and founder of joimax®. “Our next development will be an EndoLIF® Cage on the basis of our iLESSYS® Delta system for posterior lumbar inter-body fusion (PLIF).”
At the same time joimax® Inc., the US subsidiary celebrates its fifth anniversary, exhibits at the AANS and for the first time awards the Parviz Kambin prize in the frame of the second international TESSYS®-User Meeting in Denver, USA.
Karlsruhe, April 6, 2011. joimax® GmbH holds the 2nd International TESSYS® User Meeting in Denver, USA on April 9th and 10th. At this event, the Karlsruhe based medical device
company starts the celebration activities on the occasion of its 10th anniversary in Germany and its 5th year of existence worldwide – a special occasion in combination with the AANS
Annual Scientific Meeting (American Association of Neurological Surgeons) from April 9th – 13th, 2011.
„We are particularly proud to announce the first ever Parviz Kambin Award“, says Wolfgang Ries, founder and CEO of joimax® GmbH. „With this award we value the neurosurgeon Dr.
Parviz Kambin’s research and work as an important pioneer in the field of minimally invasive spinal surgery. The TESSYS® procedure uses what is known as the Kambin-triangle as its
point of access to the spinal canal.“
The User Meeting offers an optimal platform for TESSYS® users, surgeons, scientists and sales partners to share their experience with the method, further technologies and case
studies as well as learn and test new products and techniques such as the iLESSYS® System, now being launched.
On April 9th, joimax® starts its celebrations with an advanced cadaver workshop which focuses on endoscopic spinal stenosis treatment with TESSYS® Stenosis, the Shrill® Shaver
Drill System and now iLESSYS® method as well. The iLESSYS® method enables the surgeon to fully endoscopically remove transforaminally difficult-to-reach herniated discs and also
stenoses via an interlaminar approach.
The joimax® founder Wolfgang Ries will also give an overview of the history of the company reflecting the past five and ten years of the company and will also provide an outlook on
future products and systems.
The scientific program of the event will include a variety of technical lectures, presentations and discussions on the TESSYS® method including reports on first experiences with the
Shrill® System and iLESSYS®.
Karlsruhe – As its latest development, joimax® presents the EndoLIF® system for endoscopic stabilization of the lumbar spine. The EndoLIF® system includes an O-cage
(oblique cage) in addition to fully endoscopic access technology to the intervertebral disc space with the proven TESSYS® or iLESSYS® technique. In addition, there is Percusys®, a screw and rod system for posterior percutaneous stabilization.
The advantages of this procedure are clear:
• Smooth, atraumatic access due to dilation of tissue
• Dura and nerves are protected by the working tubes
• Dorsal bone structures are unaffected
• O-cage made from titanium with honeycomb structure as optimal subsurface for cell growth
• Percutaneous stabilization with a screw and rod system, so minimally invasive too Both new systems are CE approved, not yet FDA cleared.
Karlsruhe (GER) / Irvine, CA – December 3, 2019 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, celebrated resounding success at this year’s German Spine Society (DWG), held November 28 to 30 in Munich, Germany. joimax® presented
its newest product innovations and hosted several informative sessions to rave reviews, exceeding expectations.
Among the products showcased was a new
member of the joimax® TESSYS® family, TESSYS® Thx,
a system specifically developed for the symptomatic thoracic deherniation and
decompression treatment. Surgeries utilizing TESSYS® Thx can
avoid complications often associated with traditional open and microsurgical
approaches, such as significant muscle damage, bony resection, and morbidities.
joimax® also presented Intracs®em,
the first electromagnetic system for endoscopic spine applications that can
navigate instruments directly at the tip, if required. This navigation system
combines side and AP images of the C-arm with the CT axial scan, providing surgeons
with meaningful views of the target region. Intracs® em received
its CE mark earlier this year and has been successful throughout Europe and
Asia. FDA approval is pending; expected by year’s end.
Moreover, joimax® presented its
Endoscopic Spine Academy ESPINEA®. This modular training program,
divided into a Pre-Clinical Training with anatomical models, endoscopic tools,
and simulators, and a Clinical Training, part of the joimax® CM3
program consisting of visitation, hands-on workshops, and the first surgery,
offers surgeons specific support to optimize and significantly shorten the
individual learning curve.
Additional highlights included, the daily
Meet the Expert Sessions, a Needle Placement Challenge with attractive prizes,
and a lunch symposium on “Endoscopy in the Course of Time”.
joimax® CEO and Founder Wolfgang Ries states, “Our unmatched attention to the needs of surgeons enables us to be one step ahead. The reception of our products at this convention reinforced our commitment to endoscopy and underscored the importance of showcasing innovative products such as Intracs®em. By participating in national and international spine congresses, we are able to achieve broad market penetration for the benefit of the patient”.
Right on time with the soon expected registrations of the joimax® products in Brazil – one of the most emerging BRIC economies – the German-based company showed a very successful presence at the third World Congress of Minimally Invasive Spine Surgery and Techniques (WCMISST) in Salvador de Bahia. The congress was supported by the main International MISS Societies. Almost 2.000 interested participants attended the congress which focused especially on promoting and enhancing the interventional minimally invasive treatment of spine diseases. joimax® is very proud of being part of this exciting development.
The eight largest emerging and developing economies by either nominal GDP or PPP are the BRIC nations (Brazil, Russia, India and China) as well as Mexico, Turkey, Indonesia, and South Korea. joimax® is represented in more than 60% of these countries – namely China, Russia, India, South Korea, and Turkey – and observes a fast growing number of registered products in these areas. In Brazil and Mexico submissions with the Health Authorities were started several months ago. The completion is expected in the near future. Then nearly 90% of the growth-leading economies will be covered.
joimax® provides the complete range of high-quality medical devices for minimally invasive endoscopic spine surgery “Made in Germany”. As a matter of course these devices are CE-marked and FDA-cleared and are sold throughout the European Union and the United States. The specific surgery methods they are used for, were developed by joimax® together with international experts and opinion leaders for the benefit of the patients:
Less pain, less trauma, less hospitalization, gain back quality of life and be back to work in shorter time!
The advantages are evident. Therefore joimax® has established a worldwide net of distribution partners allowing that as many patients as possible can get access to these progressive therapy methods.
Other important countries where joimax® is already present are: South Africa, Israel and Australia. One of the company’s goals within the next few years is to achieve the approval for its devices with the Japanese Ministry of Health.
Emerging and growth-leading economies are the key markets that are expected to lead global growth in the next 10 years. “joimax® is most pleased with its growing market penetration also in these countries, hence promoting these gentle, patient-friendly and economically beneficial surgery methods for the sake of the patients and of the health insurance systems at the same time”, states Wolfgang Ries, CEO and Founder of joimax®.
During a special joimax® faculty meeting which was held at the institute of anatomy at the University of Mainz, Germany on June 20-21, joimax® honored three surgeons with the Parviz Kambin Award. Dr. Albert Telfeian, Rhode Island Hospital, Brown University, RI, US and Dr. Gabriele Jasper, Center for Pain Control, NJ, US received the award in recognition of their outstanding scientific and educational dedication to transforaminal surgery. The two surgeons tremendously contributed to this field with numerous high quality publications. Also they are treading new paths for spinal endoscopy. Just recently Dr. Telfeian did the first awake surgery to remove a thoracic spinal tumor. Dr. Menno Iprenburg, Iprenburg Herniakliniek, NL received the award for his lifetime achievement. Dr. Iprenburg is applying joimax techniques, especially TESSYS, since 2004. In his private clinic, he successfully treated more than 2000 patients suffering from disc herniations.
The award is named after Dr. Parviz Kambin who identified a workspace within the intervertebral foramen, through which the spinal canal can be accessed safely. Because this safe zone is somewhat triangular shaped, it was named the „Kambin triangle“.
On the left: Award winner Dr. Menno Iprenburg (r.) with joimax® CEO Wolfgang Ries (l.)
On the right: Award winners Dr. Albert Telfeian (r.) and Dr. Gabriele Jasper (l.) with Wolfgang Ries (m.)
Spine specialists take part at the joimax® endoscopy workshop with live spinal surgeries
Karlsruhe, 14 March 2011: On 17 and 18 March 2011, the Medical University as well as the Institute for Anatomy in Graz, Austria, were the sites of a two-day international joimax® Workshop focused on the endoscopic resection of herniated discs utilizing the TESSYS® method. The first day, Dr. Wolfgang Kreil and Univ. Doz. Dr. med. Sandro Eustacchio of the Medical University Graz will operate on two patients with herniated discs using the TESSYS® method. The participating orthopaedic surgeons and neurosurgeons from Germany, Austria, Greece, Bulgary, Italy and Macedonia will experience the surgery procedure firsthand. While operating on the patients, one of the operating surgeons will explain each step of the TESSYS® surgery and answer questions of the workshop attendees. Afterwards Dr. Wolfgang Kreil and Dr. Sandro Eustacchio will lead scientific presentations and panel discussions on how the transforaminal endoscopic technique works and what their experiences have been, while discussing several case examples.
On the second day, joimax® hosts an intensive cadaver training course at the Institute for Anatomy Graz. The practical training and hands-on learning experience gained at cadaver workshops such as this one is an important first step in the three-step joimax® CM3 Education Program. In this comprehensive program, experienced surgeons and application specialists train each workshop member to use the TESSYS® Method. The subsequent steps of the Education Program are visitations, followed by live surgeries accompanied by joimax® Medical Trainers and application specialists.
Sie sehen gerade einen Platzhalterinhalt von reCAPTCHA. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
